taurine has been researched along with Diabetic Neuropathies in 12 studies
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Taurine alleviated mechanical allodynia, mechanical hyperalgesia, and thermal hyperalgesia in CCI rats and suppressed mechanical allodynia and hyperalgesia in diabetic rats." | 3.77 | Antinociceptive effect of intrathecal administration of taurine in rat models of neuropathic pain. ( Hara, K; Haranishi, Y; Sata, T; Terada, T, 2011) |
| "Taurine has been found to ameliorate the diabetic neuropathy and control apoptosis in various tissues." | 1.51 | Protective Effect of Taurine on Apoptosis of Spinal Cord Cells in Diabetic Neuropathy Rats. ( Li, K; Piao, F; Shahbaz, M; Shi, X; Suleman, R; Taj, A; Wu, P; Zhang, M, 2019) |
| "The etiology of painful diabetic neuropathy is poorly understood, but may result from neuronal hyperexcitability secondary to alterations of Ca2+ signaling in sensory neurons." | 1.33 | Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. ( Abatan, O; Larkin, D; Li, F; Obrosova, IG; Stevens, MJ; Stuenkel, EL; Tian, D, 2005) |
| "Flurbiprofen treatment of ND rats replicated many of the biochemical and physiological abnormalities of EDN, i." | 1.31 | Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration. ( Greene, DA; Larkin, D; Li, F; Marinescu, V; Pop-Busui, R; Stevens, MJ; Sullivan, K; Van Huysen, C, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, K | 3 |
| Shi, X | 3 |
| Luo, M | 1 |
| Wu, P | 3 |
| Zhang, M | 3 |
| Zhang, C | 1 |
| Li, Q | 1 |
| Wang, Y | 1 |
| Piao, F | 3 |
| Suleman, R | 2 |
| Shahbaz, M | 1 |
| Taj, A | 1 |
| Qiu, Z | 1 |
| Aadil, RM | 1 |
| Agca, CA | 1 |
| Tuzcu, M | 1 |
| Hayirli, A | 1 |
| Sahin, K | 1 |
| Askwith, T | 1 |
| Zeng, W | 1 |
| Eggo, MC | 1 |
| Stevens, MJ | 6 |
| Ivanov, DA | 1 |
| Gnusaev, SF | 1 |
| Elizarova, EP | 1 |
| Iakovlev, BN | 1 |
| Terada, T | 1 |
| Hara, K | 1 |
| Haranishi, Y | 1 |
| Sata, T | 1 |
| Pop-Busui, R | 2 |
| Marinescu, V | 1 |
| Van Huysen, C | 3 |
| Li, F | 2 |
| Sullivan, K | 1 |
| Greene, DA | 2 |
| Larkin, D | 2 |
| Obrosova, IG | 2 |
| Abatan, O | 1 |
| Tian, D | 1 |
| Stuenkel, EL | 1 |
| Lattimer, SA | 1 |
| Kamijo, M | 1 |
| Sima, AA | 1 |
| Sullivan, KA | 1 |
| Bayer, L | 1 |
| Cao, X | 1 |
| Towns, R | 1 |
| Fathallah, L | 1 |
1 review available for taurine and Diabetic Neuropathies
| Article | Year |
|---|---|
Taurine ameliorates neuropathy via regulating NF-κB and Nrf2/HO-1 signaling cascades in diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Heme Oxygenase-1; NF-E2-Related Fac | 2014 |
11 other studies available for taurine and Diabetic Neuropathies
| Article | Year |
|---|---|
Taurine protects against myelin damage of sciatic nerve in diabetic peripheral neuropathy rats by controlling apoptosis of schwann cells via NGF/Akt/GSK3β pathway.
Topics: Animals; Apoptosis; Demyelinating Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; | 2019 |
Protective Effect of Taurine on Apoptosis of Spinal Cord Cells in Diabetic Neuropathy Rats.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Rats; Rats, Spragu | 2019 |
The microRNAs Expression Profile in Sciatic Nerves of Diabetic Neuropathy Rats After Taurine Treatment by Sequencing.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; MicroRNAs; Rats; Sciatic Nerve; Tau | 2019 |
Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy.
Topics: Aldehyde Reductase; Antioxidants; Biological Transport; Cells, Cultured; Diabetic Neuropathies; Dose | 2009 |
[Efficacy of metabolic therapy in prevention and treatment of adolescents with diabetic autonomic cardiovascular neuropathy].
Topics: Adolescent; Blood Pressure; Chemoprevention; Child; Diabetes Mellitus, Type 1; Diabetic Neuropathies | 2010 |
Antinociceptive effect of intrathecal administration of taurine in rat models of neuropathic pain.
Topics: Analgesics; Animals; Behavior, Animal; Diabetic Neuropathies; Disease Models, Animal; Dose-Response | 2011 |
Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.
Topics: Acetylcarnitine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase | 2002 |
Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats.
Topics: Adenosine Triphosphate; Animals; Blood Glucose; Body Weight; Caffeine; Calcium Signaling; Central Ne | 2005 |
Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic N | 1993 |
Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
Topics: Animals; Anti-Bacterial Agents; Blood Flow Velocity; Blood Glucose; Blood Pressure; Body Weight; Car | 2001 |
Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy.
Topics: Aldehydes; Animals; Ascorbic Acid; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diab | 2001 |